The University of Pennsylvania will officially open the region’s premier facility for advanced research, education, and innovative public/private partnerships in nanotechnology on October 4.
Perelman School of Medicine
Garret FitzGerald, MD, FRS, professor of Medicine and Pharmacology; chair of the Department of Pharmacology; and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine, University of Pennsylvania is the 2013 recipient of the Jay and Jeanine Schottenstein Prize in Cardiovascular Sciences from The Ohio State University Wexner Medical Center’s Heart and Vascular Center.
One of the biggest changes to the health care system is coming in just a few short weeks: the individual mandate.
Penn Medicine: Treating Brain Cancer with Neurosurgical Resection and Chemotherapeutic Wafers Can Improve Cognitive Function
A new approach to treating cancer that has spread to the brain is able to preserve and, in some cases, improve cognitive function in patients, while achieving local control of tumor progression.
Penn Medicine: Made to Order at the Synapse: Dynamics of Protein Synthesis at Neuron Tip is Basis for Memory and Learning
Protein synthesis in the extensions of nerve cells, called dendrites, underlies long-term memory formation in the brain, among other functions.
The precise targeting and limited dosing of radiation via proton therapy is proving to be an advantage in ongoing efforts to reduce treatment side effects among head and neck cancer patients, according to a new study of pediatric patients from researchers at the Perelman School of Medicine at the University of Pennsylvania.
At least 30 percent of patients in intensive care units (ICUs) suffer some form of mental dysfunction as reflected in anxiety, depression, and especially delirium.
Pancreatic cancer ranks as the fourth-leading cause of cancer death in the United States, and is one of the most deadly forms of cancer, due to its resistance to standard treatments with chemotherapy and radiation therapy and frequently, its late stage at the time of diagnosis.
Penn Study Shows New Islet Cell Transplant Procedure Offers Improved Outcomes for Patients with Type 1 Diabetes
The latest approach to islet transplantation, in which clusters of insulin-producing cells known as islets are transplanted from a donor pancreas into another person’s liver, has produced substantially improved results for patients with type 1 diabetes, and may offer a more durable alternative to a whole pancreas transplant.